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Edited by Lukas HuberAbstract Small heat shock proteins prevent abnormal protein
folding and accumulation. We analyzed the expression of
hsp27 and aB-crystallin in skeletal muscle specimens of patients
with desminopathies, plectinopathies, myotilinopathy, and other
myoﬁbrillar myopathies by means of diﬀerential centrifugation,
2D-gel electrophoresis, Western blotting, and mass spectrome-
try. Hsp27-P82 and -P15 as well as aB-crystallin-P59 and
-P45 are the major serine phosphorylation isoforms in normal
and diseased human skeletal muscle. 2D-gel-electrophoresis re-
vealed spots of hsp27 in a range of pH 5.3–6.4 in samples of
all skeletal muscle specimens, except for the seven desminopa-
thies. They indicated a shift of the main hsp27-spot to alkaline
pH degrees, which may help to diﬀerentiate primary desminopa-
thies from other myopathies with structural pathology of the des-
min cytoskeleton.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Mutations in the human desmin, aB-crystallin, myotilin, and
plectin genes all give rise to progressive myopathies, which are
morphologically characterized by myoﬁbrillar abnormalities
and abnormal cytoplasmic accumulation of desmin-immuno-
reactive material [1–4]. These genetically deﬁned disorders
share clinical as well as myopathological abnormalities with*Corresponding author. Fax: +49 228 287 5024.
E-mail address: rolf.schroeder@ukb.uni-bonn.de (R. Schro¨der).
0014-5793/$30.00  2005 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2005.05.051the large group of myoﬁbrillar myopathies, which comprise
sporadic and familial neuromuscular conditions of consider-
able clinical and genetic heterogeneity [5]. The vast majority
of myoﬁbrillar myopathies are due to so far unidentiﬁed gene
defects [4]. In addition, rare symptomatic forms, some in re-
sponse to drug treatment have been described [5]. To date,
the deﬁnite diagnosis of a primary desminopathy, aB-crystal-
linopathy or myotilinopathy can only be established by means
of direct gene sequencing.
Accumulation of the small heat shock proteins hsp27
(HspB1) and aB-crystallin along with desmin-positive aggre-
gates is a characteristic, though basically non-speciﬁc
immuno-histochemical feature in all disease entities listed
above as well as in central core disease and neurogenic atrophy
[1,3,6,7]. Among a variety of other functions, small heat shock
proteins have been postulated to exert an essential role in pre-
venting abnormal protein folding and accumulation [8]. In par-
ticular, hsp27 has been shown to suppress the formation of
pathological protein aggregates induced by the R120G aB-
crystallin mutant [9]. Phosphorylation is known as the major
post-translational modiﬁcation of aB-crystallin and hsp27 in
response to multiple forms of cellular stress [10], but the
expression patterns of hsp27 and aB-crystallin protein iso-
forms in normal and diseased human skeletal muscle have
not been studied so far.
We studied the expression patterns of hsp27 and aB-crystal-
lin protein isoforms as well as their diagnostic value in samples
of skeletal muscle specimens derived from patients with des-
minopathies, plectinopathies, myotilinopathy, and myoﬁbrillar
myopathies by means of diﬀerent biochemical protein separa-
tion techniques in conjunction with immunoblotting and mass
spectrometry to gain further insight in the role of small heat
shock proteins in myopathies with structural pathology of
the intermyoﬁbrillar desmin cytoskeleton.ation of European Biochemical Societies.
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2.1. Muscle biopsies
Nineteen muscle specimens obtained from 19 patients were included
in this study: (i) seven patients belonging to ﬁve diﬀerent families with
genetically conﬁrmed desminopathies (patient 1 (DM1): K239fsX242
[6]; patients 2 and 3 (DM2 and DM3): E359_S361del [11]; patients 4
and 5 (DM4 and DM5): E359_S361del [11]; patient 6 (DM6):
R350P, Schro¨der et al., manuscript in preparation; patient 7 (DM7):
R454W, Goudeau et al., manuscript in preparation); (ii) two patients
with genetically conﬁrmed epidermolysis bullosa simplex with muscu-
lar dystrophy (EBS-MD) due to plectin mutations (patient 1 (PM1):
13803ins16/13803ins16 [3]; patient 2 (PM2): compound heterozygote
(recessive) mutations 5083DelG and 2745DelC, G. Meneguzzi, Nice,
France, to be published elsewhere); (iii) one patient with myotilinopa-
thy (LM1): S55F, Fischer et al., manuscript in preparation; (iv) six
cases with myoﬁbrillar myopathies (MM1–MM6), in which desmin,
aB-crystallin, and myotilin (exon 2) mutations had been ruled out by
genetic testing; (v) normal control muscle tissue was obtained from
three patients (C; only one of them is shown). Due to the limited
amount of muscle, samples of the three specimens DM6, DM7 and
PM2 were only included in the 2D-gel analysis.2.2. Antibodies
The following primary and secondary antibodies were used: desmin
monoclonal (Sigma; 1:2000), hsp27 monoclonal (stressgen; 1:1000),
and aB-crystallin polyclonal (stressgen; 1:2000). The serine residue
phosphorylation site-speciﬁc polyclonal antibodies aB-crystallin-P59
(1:1000), -P45 (1:500), -P19 (1:500), hsp27-P82 (1:1000), -P78
(1:1000), and -P15 (1:500) were generated by Kato et al. [12]. Peroxi-
dase-coupled secondary antibodies (1:10000) were purchased from
Sigma.
2.3. Preparation of muscle samples, 1D and 2D-gel electrophoresis, and
Western blotting
To separate the soluble from the insoluble muscle protein fraction,
5 mg of each human skeletal muscle specimen were pulverized by a pes-
tle at 80 C, suspended on ice in 200 ll lysis buﬀer (80 mM HEPES–
NaOH, pH 7.0, 1 mM PMSF, 1 mM EDTA, complete mini protease
inhibitor (Roche), homogenized 1 min by soniﬁcation on ice (Soniﬁer
UP200S dr. hielscher) and centrifuged for 1 min at 1000 · g. 10 ll of
the resulting supernatant was used for a Bradford assay to determine
the protein content. Afterwards the remaining supernatant and pellet
were mixed again and diﬀerences in the individual protein content were
adjusted by addition of lysis buﬀer. 100 ll of each sample were further
centrifuged at 125000 · g for 20 min at 4 C. The resulting pellet was
resuspended in 200 ll lysis buﬀer, soniﬁcated and centrifuged again.
The ﬁrst supernatant and the remaining pellet of each sample were ad-
justed to equal volume with lysis buﬀer and used for 1D-SDS–PAGE
and Western blotting analysis, carried out as described previously
[6,13].
2D-gel electrophoresis was performed using an adaptation of the
protocols described by Go¨rg et al. [14], Rabilloud et al. [15] and the
Amersham–Pharmacia Biotech protocol. 2 mg of each muscle speci-
men was cut at 80 C, lysed in 200 ll lysis buﬀer (7 M urea, 2 M thio-
urea, 4% CHAPS, 40 mM Tris, 2% IPG-buﬀer, 2% DTT, 1 mM
PMSF, protease inhibitor (Roche), bromophenol blue) at room tem-
perature, homogenized and centrifuged at 16000 · g for 5 min. Sam-
ples of the supernatants were loaded with cups placed at the anodic
and cathodic side of rehydrated 18 cm IPG-strips (pH 4–7 linear), fo-
cused at 22 C (Multiphor II horizontal) using the voltage gradient
(power supply EPS 3501XL; 50 kVh) linearly increased on 400 V dur-
ing 30 min, followed by 400 V for 4 h, linearly increased on 3500 V
during 5 h, followed by 3500 V for 12.5 h. Afterwards, strips were pre-
pared for the second dimension as described below, followed by Wes-
tern blotting analysis.2.4. Preparation of muscle samples for mass spectrometry
150 mg of the muscle specimens C and DM2 were lysed in 500 ll ly-
sis buﬀer and homogenized as described above. The samples addition-
ally were soniﬁed four times with 15 strokes (soniﬁer UP200S,
dr.hielscher) on ice preceding the centrifugation step. Both superna-
tants were concentrated and the buﬀer exchanged against rehydrationbuﬀer using 5 kDa centrifugal ﬁlters (Millipore, UFV4BCC25), and
the protein concentration was quantiﬁed using the 2D-quant kit
(Amersham Biosciences).
For IEF aliquots of 250 lg (analytical gels) and 500 lg (preparative
gels) protein of the samples were diluted with rehydration buﬀer to a
volume of 350 ll and applied to the IEF-strips (18 cm, pH 3–10 non-
linear) via the rehydration technique according to Go¨rg et al. [16] for
12 h at 50 V. The strips then were focused on the IPGphor system
(Amersham Biosciences) with a current limit of 50 lA per strip at 20 C
with the following program: 1 h at 200 V, 1 h at 500 V, 1 h at 1000 V,
gradient to 8000 V in 1 h, and a ﬁnal focusing step at 8000 V for 28 kVh.
After IEF the strips were brieﬂy rinsed in H2O and prepared for the
second dimension by a two-step equilibration and cysteine alkylation
process. The strips were incubated two times in equilibration buﬀer
(Tris/HCl 50 mM, pH 8.8; 6 M Urea; 30%, v/v, glycerol; bromophenol
blue) for 12 min, in which 1% (w/v) DTT (step one) or 4% (w/v) iodo-
acetamide (step two) were added, respectively.
Subsequently, the strips were loaded on SDS gels (12.5% acrylamide)
containing a small stacking gel according to Laemmli [17]. Molecular
weight standards were applied on a piece of ﬁlter paper positioned next
to the basic end of the strip. Electrophoresis was carried out on a Hoe-
fer SE 600 system at 20 C for which the current was limited to 25 mA
per gel.
After electrophoresis, the gels were ﬁxed with 40% (v/v) EtOH/10%
(v/v) acetic acid overnight and stained with colloidal Coomassie bril-
liant blue to visualize the protein spots. Putative hsp27 protein spots
were picked manually and prepared for digestion with trypsin by
sequential incubation in H2O, 50% (v/v) and 100% (v/v) acetonitrile
(HPLC quality each). The dried gel plugs were soaked in 10 ll
NH4HCO3 (25 mM) containing 10 ng/ll trypsin (Promega, sequencing
grade) on ice for 1 h. The remaining trypsin solution was removed,
7.5 ll of NH4HCO3 buﬀer (25 mM) were added to the swollen plugs,
and digestion was carried out at 37 C overnight. Next day the diges-
tion was stopped by addition of 1.5 ll TFA (1%, v/v) and the peptides
were eluted for a period of 1 h at RT.
To investigate possible phosphorylation of the resulting peptides 2 ll
of the digests were incubated with 0.05 units of alkaline phosphatase of
calf intestine (Fluka) in 50 mM NH4HCO3 in a total volume of 10 ll.
To analyze the digests by mass spectrometry 0.8 ll of the digests were
spotted together with 1.6 ll of dihydroxy-benzoic acid (5 mg/ml) in 1:2
ACN/0.1% (v/v) TFA on an anchor chip target (Bruker) and after crys-
tallization analyzed on a MALDI-TOF (Reﬂex IV, Bruker). Spectra
were recorded in positive reﬂector mode using an accelerating voltage
of 20 kV and annotated with the help of the Flex Analysis software
(Bruker). The identities of the protein spots were checked by peptide
mass ﬁngerprint employing the Mascot software (Matrix Science).
The extracted peak lists were searched twice against the non-redundant
NCBI database with mass tolerance of 100 or 250 ppm allowing one or
two miscleavages, respectively. Positively identiﬁed hsp27 isoforms
were further analyzed for post-translational modiﬁcations like phos-
phorylation, methylation, deamidation, ubiqutination, and biotinyla-
tion by including the respective mass modiﬁcations.3. Results
3.1. Hsp27 and aB-crystallin protein isoforms in normal human
skeletal muscle
To study small heat shock protein isoform expression as well
as their distribution between soluble and insoluble muscle pro-
tein fractions, we performed diﬀerential centrifugation of mus-
cle tissue lysates in conjunction with 1D-gel electrophoresis
and immunoblotting using serine phosphorylation site-speciﬁc
hsp27 and aB-crystallin antibodies. In normal muscle, all three
hsp27 isoforms were present in the pellet fraction with hsp27
P82 and P15 showing the strongest signal intensity (Fig. 1).
Analysis of aB-crystallin protein isoform expression in normal
skeletal muscle showed a positive signal for the aB-crystallin
P45 and P59 isoforms, both of which were exclusively found
in the pellet fraction. In contrast, staining for aB-crystallin
P19 was negative (Fig. 2).
Fig. 1. Proteins of normal and diseased human skeletal muscle samples were separated by 12% SDS–PAGE followed by Western blot analysis using
hsp27 and desmin antibodies. Note that total protein extracts were used for hsp27 Western blotting in the upper lane, whereas Western blotting for
desmin and the phosphorylation site-speciﬁc hsp27 isoforms was performed after diﬀerential centrifugation at 125000 · g. Abbreviations: C, normal
human skeletal muscle; DM, desminopathy; PM, plectinopathy; LM, myotilinopathy; MM, myoﬁbrillar myopathy; S, supernatant; P, pellet fraction.
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protein extracts from normal human skeletal muscle revealed a
prominent spot at pH 6.0, which corresponds well with the cal-
culated pI. Furthermore, a second distinct spot at pH 5.5 was
occasionally detected in normal muscle tissue (Fig. 3, only one
of the three control specimens is shown) as well as in the dis-
eased specimens. This spot reﬂects phosphorylated isoforms.
Analogously, an antibody against aB-crystallin showed a main
immunoreactive spot at pH 7.5 (calculated pI 6.8; data not
shown).
3.2. Hsp27 protein isoforms in desminopathies, plectinopathies,
myotilinopathies and myoﬁbrillar myopathies
Analysis of total hsp27 protein expression showed that the le-
vel of hsp27 was similar in all samples except for the myotilin-Fig. 2. Proteins of normal and diseased human skeletal muscle samples were
aB-crystallin and desmin antibodies. Note that total protein extracts were use
blotting for desmin and the phosphorylation site-speciﬁc aB-crystallin iso
Abbreviations: C, normal human skeletal muscle; DM, desminopathy; PM,
supernatant; P, pellet fraction. Note the strong signal intensity of aB-crystalopathy and three myoﬁbrillar myopathies (LM1, MM1,
MM2, MM4), which showed decreased protein levels (Fig. 1).
In analogy to normal human muscle, in general hsp27 P82
was present in the pellet fraction of all diseased muscle samples.
However, in samples DM2, DM4, DM5, MM5, and to a lesser
degree in PM1 andMM3, hsp27 P82 was also present in the sol-
uble fraction. It is noteworthy that the presence of hsp27 P82 in
the soluble fraction was always associated with a shift of desmin
to the soluble fraction. Analysis of hsp27 P15 showed that this
isoform was also detectable in the majority of diseased muscle
samples. However, samples DM1 and PM1 lacked the hsp27
P15 isoform, DM5,MM1 andMM2 showed a reduced amount,
and MM2 andMM5 exhibited a shift of this isoform to the sol-
uble fraction. The hsp27 P78 isoform showed only a faint signal
in the pellet fraction of DM1, DM3, DM4, PM1 and MM5.separated by 12% SDS–PAGE followed by Western blot analysis using
d for aB-crystallin Western blotting in the upper lane, whereas Western
forms was performed after diﬀerential centrifugation at 125000 · g.
plectinopathy; LM, myotilinopathy; MM, myoﬁbrillar myopathy; S,
lin P19 in PM1.
Fig. 3. Protein extracts of normal and diseased human skeletal muscle
specimens were separated by 2D-gel-electrophoresis followed by
Western blot analysis using an hsp27 antibody. Abbreviations: C,
normal human skeletal muscle; DM, desminopathy; PM, plectinopa-
thy; LM, myotilinopathy; MM, myoﬁbrillar myopathy. DM 3 & C, co-
migration of sample DM 3 and the control C. The calculated pI of
hsp27 is 6.0. Note the shift of the main hsp27 positive spot to alkaline
pH in all seven desminopathies.
Fig. 4. Protein extracts of normal (specimen C, inset) and diseased
(specimen DM2) human skeletal muscle were separated by 2D-gel-
electrophoresis followed by colloidal Coomassie brilliant blue staining.
The four spots indicated represent two hsp27 isoforms in each muscle
specimen. Hsp27 was identiﬁed by mass spectrometry (MALDI), with
high signiﬁcance (mowse score value) and a high degree of sequence
coverage. The hsp27 protein within the spots 2 and 4 demonstrated a
phosphorylation of Ser82 as the only post-translational modiﬁcation
detected by mass spectrometry. The three tetra-peptides MTER,
ALSR, and CFTR are not detectable.
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protein extracts derived from all the desminopathy cases re-
vealed an aberrant hsp27 pattern when compared to normal
and disease controls (Fig. 3). All seven muscle samples showed
a slight to moderate alkaline shift of the main hsp27 positive
spot to pH 6.1–6.2. This shift was most pronounced in DM1,
DM6 and DM7. To conﬁrm this alkaline shift in primary des-
minopathies, samples of DM3 and the control specimen were
mixed which resulted in two merging spots at the same relative
positions as obtained in the analysis of the single samples. In
contrast, samples derived from the three normal controls, both
plectinopathies, the myotilinopathy, and all six myoﬁbrillar
myopathies showed a main hsp27 positive spot at pH 6.0.To further investigate the nature of a putative post-transla-
tional modiﬁcation causing this alkaline shift, samples of the
control and DM2 specimens again were separated by 2D-gel-
electrophoresis and stained with colloidal Coomassie brilliant
blue (Fig. 4). Among others, the indicated spots 1–4 were
picked, the included protein digested and subjected to mass
spectrometry using the MALDI technique. The analysis re-
sulted in the identiﬁcation of two hsp27 isoforms in each mus-
cle specimen. One post-translational modiﬁcation was detected
in the acidic hsp27 spot of each muscle specimen (spots 2 and
4) and identiﬁed as phosphorylation of Ser82, conﬁrmed by
dephosphorylation in vitro.
3.3. aB-crystallin expression in desminopathies, plectinopathies,
myotilinopathies and myoﬁbrillar myopathies
aB-crystallin was detected by immunoblot analysis showing
that this small heat protein is present in all samples analyzed.
Samples DM3, DM4 and MM5 showed increased signal inten-
sities whereas DM1 displayed only a faint immunoreaction. As
in normal controls, aB-crystallin P59 and P45 were the prom-
inent serine phosphorylation site-speciﬁc isoforms associated
with the pellet fraction. A marked aB-crystallin P19 signal
intensity was found in PM1 and, to a lesser degree, in DM3.
Our 2D-gel analysis in conjunction with aB-crystallin immu-
noblotting showed a main immunoreactive spot at pH 7.5 in
all samples analyzed with no apparent diﬀerences between nor-
mal and diseased muscle (data not shown).4. Discussion
We analyzed the expression pattern of hsp27 and aB-crystal-
lin isoforms in normal human skeletal muscle and muscle biop-
sies from patients with desminopathies, plectinopathies,
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previous studies in normal murine skeletal muscle [12], hsp27
P82 and P15 as well as aB-crystallin P59 and P45 were the ma-
jor serine phosphorylation site-speciﬁc isoforms in normal hu-
man skeletal muscle. All four small heat shock protein
isoforms were primarily associated with the insoluble des-
min-positive cytoskeletal pellet fraction. In contrast, hsp27
P78 only gave a weak signal in the pellet fraction and aB-crys-
tallin P19 could not be detected in normal control tissue.
Apart from a strong aB-crystallin P19 signal exclusively
found in PM1 muscle, our analysis did not reveal any signiﬁ-
cant changes in the expression pattern of aB-crystallin and
its phosphorylation site-speciﬁc protein isoforms when com-
paring normal human control muscle with all the disease enti-
ties included in this study. In contrast, the results of our hsp27
immunoblotting studies were far more complex. The hsp27
P82 isoform was present in the pellet fraction of all diseased
muscle samples. However, in some samples hsp27 P82 could
also be detected in the supernatant fraction and this shift to
the soluble fraction was always accompanied by a shift of des-
min to the same compartment. The hsp27 P15 isoform was
present in the majority of diseased muscle samples. Samples
DM1 and PM1 lacked any signal for the hsp27 P15 isoform,
DM5, MM1 and MM2 showed a reduced signal, and MM2
and MM5 further exhibited a shift of this isoform to the solu-
ble fraction. The functional role of these changes both in terms
of presence and abundance of hsp27 P82 and P15 in individual
diseased muscle samples is not clear at present.
With regard to diagnostic purposes, it is noteworthy that
2D-gel electrophoresis revealed an aberrant hsp27 pattern in
all seven cases of desminopathy irrespective of the individual
mutation type including missense, insertion, and deletion
mutations. They showed a slight to moderate shift of the main
hsp27 spot to alkaline pH degrees. In contrast, normal con-
trols as well as samples derived from the two plectinopathies,
the myotilinopathy, and all six myoﬁbrillar myopathies
showed a main hsp27 immunoreactive spot constantly at pH
6.0, a value also calculated from the peptide sequence. This
shift is not simply secondary due to abnormal desmin accumu-
lation, because all muscle biopsies included showed myoﬁbril-
lar abnormalities and abnormal cytoplasmic accumulation of
desmin-immunoreactive material when examined by means
of immunocytochemistry.
In theory, several post-translational modiﬁcations seem to
be unlikely. Gln or Glu allowing N-terminal oxidation is not
present, demethylation of the two Met into homocystein or
hydroxylation would be neutral, glycation (glycosylation) of-
ten indicates an acidic shift and moreover, higher degrees of
glycation would exhibit a vertical trail in the second dimen-
sion. Ubiquitination has to indicate an increase in molecular
size of at least 8.5 kDa. Unspeciﬁc carbamylation is a highly
unlikely reason, as the analysis has been carried out under
accurate conditions. A highly convincing explanation of this
alkaline shift omitting noticeable changes in the molecular
weight would be methylation, which could mask acidic amino
acid residues (Asp, Glu) present in the hsp27 amino acid se-
quence. Protein methylation is thought to have important roles
in signaling pathways and protein sorting [18–20].
We therefore extended our analysis and subjected samples
of the control and the DM2 specimen to mass spectrometry
using the MALDI technique. Clear spectra were obtained,
allowing the identiﬁcation of the hsp27 isoforms with highsequence coverage, and further analyzed for post-translational
modiﬁcations like phosphorylation, methylation, deamidation,
ubiqutination, biotinylation, and truncation of the hsp27 poly-
peptide. Only a phosphorylation at one position corresponding
to the serine residue at position 82 was clearly detected among
the acidic isoforms (spots 2 and 4), but not among the more
alkaline isoforms (spots 1 and 3). Thus, modiﬁcations of the
hsp27 proteins, which could have explained the alkaline shift
of the main hsp27 spot found for the desminopathies, were
excluded. In this regard it should be noted that 6% of the
hsp27 polypeptide were not detectable and that chemically
instable post-translational modiﬁcations may be lost during
the MALDI procedure.
However, our ﬁndings indicate that 2D-gel electrophoresis
of total muscle protein extracts in conjunction with hsp27
immunoblotting is helpful to diﬀerentiate primary desminopa-
thies from other myopathies with structural pathology of the
intermyoﬁbrillar desmin cytoskeleton.Acknowledgments: We thank Dr. G. Meneguzzi, who kindly provided
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